-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
DICE Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q2 2023.
- DICE Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$39.5M, a 81.6% decline year-over-year.
- DICE Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$119M, a 62.7% decline year-over-year.
- DICE Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$88.2M, a 85.3% decline from 2021.
- DICE Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$47.6M, a 101% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)